Print this page    •   Back to Web version of article

Report Card Research Background: Pharmaceutical Company HIV/AIDS Report Card -- Research Methodology and Scoring

September 10, 2009


ATAC Report Card

Research Methodology

ATAC's Drug Development Committee completed its independent review of the pharmaceutical industry in June 2009. The information in the HIV/AIDS Report Card was gathered from interviews with pharmaceutical companies and data taken from publicly-available sources. Each company was assigned an ATAC representative who led the data collection and reporting for that company. All voting ATAC Drug Development Committee members then suggested a grade for each company in each of the five areas (drug development portfolio and plans, access to drugs, pricing, community relations and marketing practices), all of which were averaged.

Criteria Used for Scoring Each Report Card Category

Drug Development Portfolio and Plan

Access to Drugs

Pricing

Community Relations

Marketing Practices

Definitions for Each Letter Grade

A = Excellent performance, demonstrates corporate leadership in this area.

B = Very Good, demonstrates actions beyond the expected.

C = Acceptable, within expectations.

D = Poor, performance subpar compared with peers.

F = Failure, performance significantly falls below minimal expectations of corporate performance.




This article was provided by AIDS Treatment Activists Coalition. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art53619.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.